As per the latest report published by Growth Plus Reports, the Global Prenatal and Newborn Genetic Testing Market was valued at US$ 5.3 billion in 2021 and is expected to reach US$ 12.70 billion by 2030 at a revenue CAGR of 10.2% during the forecast period 2022 to 2030. The study provides a throughout analysis of the most successful strategies, market trends, drivers and opportunities, competitive landscape, market size, statistics, forecasts, and key investment areas.
Key Takeaways:
- The rise in the incidence of Down’s syndrome and other genetic disorders is growing the market revenue.
- Increase in R&D activities in the discovery & development of novel screening methods.
- The rise in awareness regarding the early detection of diseases provides lucrative revenue during the forecast period.
Request a Sample Copy of the Research Report: https://www.growthplusreports.com/inquiry/request-sample/prenatal-and-newborn-genetic-testing-market/7870
Prenatal and Newborn Genetic Testing Market Scope
| Report Attribute | Details |
| Market size value in 2021 | US$ 5.3 billion |
| Revenue forecast in 2030 | US$ 12.70 billion |
| Growth Rate | CAGR of 10.2% from 2022 to 2030 |
| Base year for estimation | 2021 |
| Forecast period | 2022-2030 |
| Segments covered | Technology, Disease, End User, and Region. |
| Regional scope | North America, Europe, Asia Pacific, and the Rest of the World (ROW) |
Market Drivers:
The global market for prenatal and newborn genetic testing is growing because of factors such as the rising prevalence of congenital malformations and genetic abnormalities, the surge in demand for non-invasive prenatal screening, the rise in unmet healthcare needs, the increased public awareness of prenatal and newborn genetic testing, the adoption of novel diagnostic methods for screening, improvements in healthcare facilities, and rising disposable incomes. However, the risk of miscarriage associated with various prenatal testing and the high price of screening procedures and diagnostic tests, and inaccurate results are expected to restrict the expansion of the global market.
Market Segmentation:
Growth plus reports have analyzed the global prenatal and newborn genetic testing market from perspectives such as technology, disease, end user, and region.
Technology Segmentation:
Based on technology, the global prenatal and newborn genetic testing market is segmented into PCR (polymerase chain reaction), aCGH (array-comparative genetic hybridization), FISH (fluorescence in-situ hybridization), Maternal Serum Screening, Amniocentesis, Chorionic Villus Sampling, Non-invasive Prenatal Testing.
The non-invasive prenatal testing (NIPT) segment accounts for the largest revenue share in the global market. This large revenue share is attributed to its high accuracy for Down syndrome, Edward’s Syndrome, and Patau syndrome, and it provides safety against conventional diagnostic methods.
Disease Segmentation:
Based on disease, the global prenatal and newborn genetic testing market is segmented into Down syndrome, phenylketonuria, cystic fibrosis, and sickle cell anemia.
Down syndrome accounts for the largest revenue share of the global prenatal and newborn genetic test market. The large share is attributed to the higher incidence rate of Down syndrome in the general population.
End-User Segmentation:
Based on the end users, the global prenatal and newborn genetic testing market is segmented into hospitals, maternity & specialty clinics, and diagnostic centers.
The hospital segment accounts for the largest revenue share of the global prenatal and newborn genetic testing market. This significant share is due to the advanced facilities and infrastructure for genetic testing attracting more patients, rising government investment in hospitals, and a higher number of experienced and trained professionals in hospitals.
Regional Growth Dynamics:
Based on region, the global prenatal and newborn genetic market is segmented into North America, Europe, Asia Pacific, and the Rest of the World.
North America dominates the global prenatal and newborn genetic testing market, followed by Europe. The largest revenue share in the market is attributed to the rise in the number of genetic disorders in the region, higher childbirth age of mothers, and increased demand for non-invasive prenatal tests (NIPT).
Request for Customization – https://www.growthplusreports.com/inquiry/customization/prenatal-and-newborn-genetic-testing-market/7870
Competitive Landscape:
The key companies operating in the global prenatal and newborn genetic testing market are:
- Bio-Rad Laboratories Inc.
- Ariosa Diagnostics Inc. (Roche)
- Agilent Technologies Inc.
- Illumina, Inc.
- Qiagen NV
- Sequenom Inc.
- Berry Genomics Co. Ltd
- BGI Group
- Laboratory Corporation of America
- Trivitron Healthcare Pvt. Ltd.
To increase the product portfolio in the prenatal and newborn genetic testing market, prominent players have embraced product launches, product approval, and agreement as key developmental strategies.
Recent Developments:
- In May 2022, the NHS created a brand-new non-invasive prenatal test that identifies the genetic alterations required to diagnose retinoblastoma. The Birmingham Women’s and Children’s NHS Foundation Trust developed this test to detect retinoblastoma risk early, improving the chance of protecting children’s vision.
- In Jan 2022, NIPD Genetics was bought by Medicover. This cutting-edge biotechnology leader actively creates, manufactures, and offers in-vitro genetic testing options. Prenatal testing technology and experience from NIPD Genetics complete and broaden Medicover’s genetic offering in its markets.
Table of Content
- INTRODUCTION
- Market Ecosystem
- Timeline Under Consideration
- Historical Years – 2020
- Base Year – 2021
- Forecasted Years – 2022 to 2030
- Currency Used in the Report
- RESEARCH METHODOLOGY
- Research Approach
- Data Collection Methodology
- Data Sources
- Secondary Sources
- Primary Sources
- Market Estimation Approach
- Bottom Up
- Top Down
- Market Forecasting Model
- Limitations and Assumptions
- PREMIUM INSIGHTS
- Current Market Trends (COVID-19 Perspective)
- Key Players & Competitive Positioning (2021)
- MARKET DYNAMICS
- Drivers
- Restraints/Challenges
- Opportunities
- GLOBAL PRENATAL AND NEWBORN GENETIC TESTING MARKET – ANALYSIS & FORECAST, BY TECHNOLOGY
- PCR (Polymerase Chain Reaction)
- aCGH (Array-Comparative Genetic Hybridization)
- FISH (Fluorescence In-Situ Hybridization)
- Maternal Serum Screening
- Amniocentesis
- Chorionic Villus Sampling
- Non-invasive Prenatal Testing
- GLOBAL PRENATAL AND NEWBORN GENETIC TESTING MARKET – ANALYSIS & FORECAST, BY DISEASE
- Down Syndrome
- Phenylketonuria
- Cystic Fibrosis
- Sickle Cell Anemia
- Others
- GLOBAL PRENATAL AND NEWBORN GENETIC TESTING MARKET – ANALYSIS & FORECAST, BY END-USER
- Hospitals
- Maternity & Specialty Clinics
- Diagnostic Centers
Buy this Premium Research Report: https://www.growthplusreports.com/checkout-7870
VALUE PROPOSITIONS RELATED TO THE REPORT:
- Powered with Complimentary Analyst Hours and Expert Interviews with Each Report
- Comprehensive quantitative and qualitative insights at segment and sub-segment level
- Covid 19 impact trends and perspective
- Granular insights at global/regional/country level
- Deep-rooted insights on market dynamics (drivers, restraints, opportunities) and business environment
- Blanket coverage on competitive landscape
- Winning imperatives
- Exhaustive coverage on ‘Strategic Developments’ registered by leading players of the market
CUSTOMIZATION OPTIONS:
- Distributor Landscape Assessment
- Pricing Intelligence
- Customer Base Assessment
- Investment & Initiatives Analysis
- ‘Business Profile’ of Key Players
Schedule a call with our analyst: https://appoint.ly/s/salesZ3Jvd3RocGx1c3JlcG9ydHMuY29t/introduction
Visit our report store at – https://www.growthplusreports.com/report-store
Browse related reports:
Infection Control Market by Product (Sterilization, Disinfection, Endoscope Reprocessing, Protective Barriers), End User (Hospitals & Clinics, Pharmaceutical & Medical Device Companies) – Global Outlook & Forecast 2022-2030
Continuous Renal Replacement Therapy Market by Product (Systems, Consumables), Modality (Continuous Venous Hemofiltration, Continuous Venous Hemodialysis), and End-user (Hospitals, Specialty Clinics) – Global Outlook & Forecast 2022-2030
Chromatography Accessories and Consumables Market by Product (Columns and Column Accessories, Autosamplers), Technologies (Liquid Chromatography, Gas Chromatography), End-user (Pharmaceutical & Biotechnology, Academic & Research Institutes) – Global Outlook and Forecast 2020-2030
Hospital Microbiology Testing Market by Product type (Instruments, Chemicals and Reagents), By Application (Gastrointestinal Infections, Respiratory Infections) – Global Outlook & Forecast Period 2022-2030
Oncology Drugs Market by Drug Class (Cytotoxic, Targeted Drugs), Indication (Lung Cancer, Breast Cancer), Therapy (Chemotherapy, Immunotherapy), Dosage Form (Solid, Liquid), Distribution Channel (Hospital Pharmacies) – Global Outlook & Forecast 2022-2030
About Us:
Growth Plus Reports is part of GRG Health, a global healthcare knowledge service company. We are proud members of EPhMRA (European Pharmaceutical Marketing Research Association).
Growth Plus portfolio of services draws on our core capabilities of secondary & primary research, market modelling & forecasting, benchmarking, analysis and strategy formulation to help clients create scalable, ground-breaking solutions that prepare them for future growth and success.
We were awarded by the prestigious CEO Magazine as “Most Innovative Healthcare Market Research Company in 2020.
Contact:
Manan Sethi
Director, Market Insights
Email: sales@growthplusreports.com
256 Chapman Road
STE 105-4, Newark,
New Castle – 19702, USA
Phone no: +1 888 550 5009
Web: https://www.growthplusreports.com/